Who we are

In the 1970s, we began the process of expanding our activities and expanding our corporate headquarters. It was also a period of strong growth in number of customers. We established partnerships and joint initiatives with major pharmaceutical industries such as Bristol-Myers Squibb, Roche and Aché.

We completed the automation process for picking at our Rio de Janeiro State Distribution Center.

We made the strategic acquisition of a wholesale distributor of pharmaceutical products in the state of São Paulo, KF Distribuidora, which had two Distribution Centers – one in the capital, and another in the city of São Carlos.

We began to operate in the Specialty segment, supplying pharmaceutical and hospital products to private clinics and hospitals.

We started operating in the Northeast region of the country with the inauguration of a Distribution Center in Salvador, in the state of Bahia.

In order to increase our product mix and capture synergies between our businesses, we began distributing vaccines through our subsidiary Promovac.

On October 26, we made the Company’s Initial Public Offering (IPO), with gross funding of R$401 million. We were pioneers in the Brazilian pharmaceutical segment as the Company’s shares began to be traded on B3.

The Profarma Institute of Social Responsibility was created in order to assist vulnerable children and teenagers through support to charitable institutions in the Profarma Group’s areas of activity.

Expanding our area of ​​operation, we inaugurated two Distribution Centers in Northeast Brazil, in the states of Pernambuco and Ceará. We also acquired Dimper, a distributor in Canoas, Rio Grande do Sul, with 11 DCs in 10 states.

As a way to strengthen our Specialty area, we acquired 60% of Prodiet Pharmaceuticals, a distribution company in the hospital segment, based in Curitiba, Paraná.

Following the Company’s strategic plan, we entered the pharmaceutical retail, with the acquisition of three chains: Drogasmil, Farmalife and Tamoio, all of them in Rio de Janeiro. Therefore, we consolidated a new positioning of Grupo Profarma, as one of the largest players in the health sector in Brazil. In the same year, we acquired the remaining 40% of Prodiet Pharmaceuticals.

We entered into a strategic partnership with AmerisourceBergen Corporation – one of the world’s largest pharmaceutical and service providers. We made a capital increase in the amount of R$187 million.

d1000 Retail Farma was established consolidating the retail division of Profarma Group. We expanded our retail area with the acquisition of Drogaria Rosário, a relevant brand in the Midwest of Brazil (Distrito Federal, Goiás, Tocantins and Mato Grosso). At the end of July that year, aiming to strengthen the Company’s capital structure, we approved a capital increase of R $ 140 million.

We made a capital increase of R$100 million with the purpose of supporting the strong growth and new composition of the Company.

In order to strengthen the capital structure, through working capital investment and debt reduction, we made a new capital increase: R $ 333 million.

With the objective of accelerating the organic expansion of our store platform and deleveraging the Group, we carried out the IPO of d1000 retail farma in August, raising R$400 million and we became part of a select group of Brazilian companies with more than one publicly traded company.

• We celebrate the 60th anniversary of Profarma Group, founded in 1961.
• In line with our growth strategy, we carried out the expansion of the Distribution Center located in the state of Rio de Janeiro and inaugurated a Distribution Center in the Federal District.
• In August 2021, Profarma, jointly with AmerisourceBergen Corporation, celebrated the sale of the equity interest in Cannes RJ Participações S.A. (“Cannes”), holding company that holds equity interest in operating companies in the specialties segment, for CM HOSPITALAR S.A.

Completion of the sale of Profarma Specialty S.A., approved by CADE in the second quarter, with the Company receiving gross proceeds of R$84.6 million from its minority stake in the specialty division.

Expansion of Profarma Distribuição’s service capacity with the opening of a second distribution center in São Paulo, which improved service levels for clients in the state’s countryside and reinforced the Company’s commitment to delivering the best service to all business partners.

Profarma Group celebrated 10 years of its entry into the retail pharmacy sector, with Rede d1000 recognized as the most efficient retail chain in Brazil according to the IBEVAR ranking. In 2023, the Group also launched Próton, its innovation hub, with the purpose of delivering health and fostering an ecosystem that enables the creation of a more innovative environment, connected with entrepreneurs, universities, and other hubs.

We expanded Distribution operations with the opening of a new distribution center in Mato Grosso, aimed at better serving demand in Brazil’s Midwest region. The area is now supported by this new facility and the existing one in the Federal District.

It was also a very significant year for Rede d1000, which was recognized for the second consecutive time as the most efficient retail chain in Brazil, according to the IBEVAR ranking.